369 related articles for article (PubMed ID: 11297260)
21. Photochemically enhanced transduction of polymer-complexed adenovirus targeted to the epidermal growth factor receptor.
Bonsted A; Engesaeter BØ; Høgset A; Maelandsmo GM; Prasmickaite L; D'Oliveira C; Hennink WE; van Steenis JH; Berg K
J Gene Med; 2006 Mar; 8(3):286-97. PubMed ID: 16342300
[TBL] [Abstract][Full Text] [Related]
22. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
Lamfers ML; Grill J; Dirven CM; Van Beusechem VW; Geoerger B; Van Den Berg J; Alemany R; Fueyo J; Curiel DT; Vassal G; Pinedo HM; Vandertop WP; Gerritsen WR
Cancer Res; 2002 Oct; 62(20):5736-42. PubMed ID: 12384532
[TBL] [Abstract][Full Text] [Related]
23. Coxsackievirus adenovirus receptor expression predicts the efficiency of adenoviral gene transfer into non-small cell lung cancer xenografts.
Qin M; Chen S; Yu T; Escuadro B; Sharma S; Batra RK
Clin Cancer Res; 2003 Oct; 9(13):4992-9. PubMed ID: 14581374
[TBL] [Abstract][Full Text] [Related]
24. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
25. Invasive behaviour of human gliomas is mediated by interindividually different integrin patterns.
Tonn JC; Wunderlich S; Kerkau S; Klein CE; Roosen K
Anticancer Res; 1998; 18(4A):2599-605. PubMed ID: 9703915
[TBL] [Abstract][Full Text] [Related]
26. Novel adenoviral gene delivery system targeted against head and neck cancer.
Li D; Guang W; Abuzeid WM; Roy S; Gao GP; Sauk JJ; O'Malley BW
Laryngoscope; 2008 Apr; 118(4):650-8. PubMed ID: 18176343
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity.
Lammering G; Hewit TH; Holmes M; Valerie K; Hawkins W; Lin PS; Mikkelsen RB; Schmidt-Ullrich RK
Clin Cancer Res; 2004 Oct; 10(19):6732-43. PubMed ID: 15475464
[TBL] [Abstract][Full Text] [Related]
28. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
[TBL] [Abstract][Full Text] [Related]
29. Adenoviral gene therapy for renal cancer requires retargeting to alternative cellular receptors.
Haviv YS; Blackwell JL; Kanerva A; Nagi P; Krasnykh V; Dmitriev I; Wang M; Naito S; Lei X; Hemminki A; Carey D; Curiel DT
Cancer Res; 2002 Aug; 62(15):4273-81. PubMed ID: 12154029
[TBL] [Abstract][Full Text] [Related]
30. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS
Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394
[TBL] [Abstract][Full Text] [Related]
31. Homing properties of adipose-derived stem cells to intracerebral glioma and the effects of adenovirus infection.
Lamfers M; Idema S; van Milligen F; Schouten T; van der Valk P; Vandertop P; Dirven C; Noske D
Cancer Lett; 2009 Feb; 274(1):78-87. PubMed ID: 18842332
[TBL] [Abstract][Full Text] [Related]
32. Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor.
Lammering G; Valerie K; Lin PS; Mikkelsen RB; Contessa JN; Feden JP; Farnsworth J; Dent P; Schmidt-Ullrich RK
Clin Cancer Res; 2001 Mar; 7(3):682-90. PubMed ID: 11297265
[TBL] [Abstract][Full Text] [Related]
33. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
Geoerger B; van Beusechem VW; Opolon P; Morizet J; Laudani L; Lecluse Y; Barrois M; Idema S; Grill J; Gerritsen WR; Vassal G
J Gene Med; 2005 May; 7(5):584-94. PubMed ID: 15651070
[TBL] [Abstract][Full Text] [Related]
34. Combined transcriptional and transductional targeting improves the specificity and efficacy of adenoviral gene delivery to ovarian carcinoma.
Barker SD; Dmitriev IP; Nettelbeck DM; Liu B; Rivera AA; Alvarez RD; Curiel DT; Hemminki A
Gene Ther; 2003 Jul; 10(14):1198-204. PubMed ID: 12833129
[TBL] [Abstract][Full Text] [Related]
35. Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.
Buttgereit P; Weineck S; Röpke G; Märten A; Brand K; Heinicke T; Caselmann WH; Huhn D; Schmidt-Wolf IG
Cancer Gene Ther; 2000 Aug; 7(8):1145-55. PubMed ID: 10975675
[TBL] [Abstract][Full Text] [Related]
36. A system for the propagation of adenoviral vectors with genetically modified receptor specificities.
Douglas JT; Miller CR; Kim M; Dmitriev I; Mikheeva G; Krasnykh V; Curiel DT
Nat Biotechnol; 1999 May; 17(5):470-5. PubMed ID: 10331807
[TBL] [Abstract][Full Text] [Related]
37. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
[TBL] [Abstract][Full Text] [Related]
38. Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma.
Shi W; Hemminki A; Bartlett JS
Gynecol Oncol; 2006 Dec; 103(3):1054-62. PubMed ID: 16870238
[TBL] [Abstract][Full Text] [Related]
39. Gene therapy for meningioma: improved gene delivery with targeted adenoviruses.
Dirven CM; Grill J; Lamfers ML; Van der Valk P; Leonhart AM; Van Beusechem VW; Haisma HJ; Pinedo HM; Curiel DT; Vandertop WP; Gerritsen WR
J Neurosurg; 2002 Aug; 97(2):441-9. PubMed ID: 12186474
[TBL] [Abstract][Full Text] [Related]
40. Conditionally replicative adenovirus expressing a targeting adapter molecule exhibits enhanced oncolytic potency on CAR-deficient tumors.
van Beusechem VW; Mastenbroek DC; van den Doel PB; Lamfers ML; Grill J; Würdinger T; Haisma HJ; Pinedo HM; Gerritsen WR
Gene Ther; 2003 Nov; 10(23):1982-91. PubMed ID: 14528322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
